Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of large language models as an information resource on functional hypothalamic amenorrhea for patients and healthcare professionals.

Frontiers in artificial intelligence·2026
Same author

Dietary Intake of Macronutrients and Micronutrients in Women with Functional Hypothalamic Amenorrhea.

Journal of women's health (2002)·2026
Same author

Impact of Estrogen Replacement on Endothelial Dysfunction and Psychological Health in Women With Hypothalamic Amenorrhea.

The Journal of clinical endocrinology and metabolism·2025
Same author

The silent pandemic of stress: impact on menstrual cycle and ovulation.

Stress (Amsterdam, Netherlands)·2025
Same author

Iatrogenic Cushing Syndrome and Adrenal Suppression Presenting as Perimenopause.

JCEM case reports·2024
Same author

Interleukin-1β induces and accelerates human endometrial stromal cell senescence and impairs decidualization via the c-Jun N-terminal kinase pathway.

Cell death discovery·2024

Related Experiment Video

Updated: Jun 23, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Does postmenopausal estrogen use confer neuroprotection?

Tammy L Loucks1, Sarah L Berga

  • 1Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia, USA.

Seminars in Reproductive Medicine
|April 30, 2009
PubMed
Summary
This summary is machine-generated.

Estrogenic agents may offer neuroprotection for the aging brain in postmenopausal women. Extended non-oral estradiol use is a reasonable option for women with low cardiovascular risk or high dementia concern.

More Related Videos

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
06:51

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration

Published on: June 7, 2012

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
09:07

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats

Published on: February 23, 2015

Related Experiment Videos

Last Updated: Jun 23, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
06:51

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration

Published on: June 7, 2012

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
09:07

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats

Published on: February 23, 2015

Area of Science:

  • Neuroscience
  • Endocrinology
  • Gerontology

Background:

  • Sex steroids significantly influence brain function throughout life.
  • Menopause leads to decreased sex steroid levels, impacting brain health.
  • Understanding the neuroprotective role of sex steroids post-menopause is crucial for women's health.

Purpose of the Study:

  • To evaluate the neuroprotective potential of sex steroids, particularly estrogenic agents, in the aging female brain after menopause.
  • To provide physicians with evidence-based information for counseling menopausal women on therapeutic options.

Main Methods:

  • Comprehensive review and synthesis of data from human studies.
  • Inclusion of relevant findings from animal, cellular, and molecular research.
  • Reconciliation of disparate evidence regarding sex steroid effects on the brain.

Main Results:

  • Available evidence suggests non-oral estradiol may be neuroprotective.
  • Extended use is a potential option for women with low cardiovascular risk or high dementia concern.
  • Estradiol's impact varies: potentially negative in unhealthy individuals, synergistic with healthy behaviors in others.

Conclusions:

  • Non-oral estradiol may be a viable neuroprotective strategy for select postmenopausal women.
  • Careful consideration of individual health status, cardiovascular risk, and dementia concern is essential.
  • Estradiol's effects are context-dependent, interacting with overall health and lifestyle factors.